115 results
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
S-12
Use of Proceeds
S-13
Dividend Policy
S-14
Dilution
S-15
Description of The Securities We Are Offering
S-17
Material U.S. Federal Income Tax … shares of common stock outstanding.
S-17
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
The following discussion describes
8-K
EX-10.1
79xo zdohl
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-3ASR
EX-4.3
n2dd49jqsfu2yol15f2
2 Jan 24
Automatic shelf registration
4:06pm
S-3ASR
sqyd2tx9
2 Jan 24
Automatic shelf registration
4:06pm
8-K
EX-10.2
pnla720a7ifsgw62
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
g6961zpsmerck91dxv6g
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
l1bv5
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
fsqbh rxf
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
v3j5 7ifo9
27 Sep 23
Prospectus supplement for primary offering
5:26pm